Cost-effectiveness analysis on the use of rFSH + rLH for the treatment of anovulation in hypogonadotropic hypogonadal women
Enrico Papaleo,1 Carlo Alviggi,2 Giorgio Lorenzo Colombo,3,4 Claudio Pisanelli,5,6 Claudio Ripellino,7 Salvatore Longobardi,8 Pier Luigi Canonico91Centro Scienze della Natalità, Gynecological-Obstetrics Department, San Raffaele Hospital, Vita-Salute San Raffaele, Milan, Italy; 2Departmen...
Main Authors: | Papaleo E, Alviggi C, Colombo GL, Pisanelli C, Ripellino C, Longobardi S, Canonico PL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-06-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/cost-effectiveness-analysis-on-the-use-of-rfsh--rlh-for-the-treatment--a17363 |
Similar Items
-
Comparison between cycles of the same patients when using recombinant luteinizing hormone + recombinant follicle stimulating hormone (rFSH), human menopausal gonadotropin + rFSH and rFSH only
by: Ahter Tanay Tayyar, et al.
Published: (2018-01-01) -
Hypogonadotropic Hypogonadism Revisited
by: Renato Fraietta, et al.
Published: (2013-01-01) -
Discontinuation of rLH two days before hCG may increase the number of oocytes retrieved in IVF
by: Session Donna R, et al.
Published: (2010-03-01) -
Increasing the Stimulation Dose of rFSH in Unexpected Poor Responders Is Not Associated with Better IVF Outcome
by: Levent Tutuncu, et al.
Published: (2012-01-01) -
The use of recombinant FSH in combination therapy in a young male with idiopathic hypogonadotropic hypogonadism
by: Yu. L. Skorodok, et al.
Published: (2018-10-01)